Human FCHSD2/NWK/SH3MD3 ORF/cDNA clone-Lentivirus plasmid (NM_014824)

Cat. No.: pGMLP001323
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human FCHSD2/NWK/SH3MD3 Lentiviral expression plasmid for FCHSD2 lentivirus packaging, FCHSD2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to FCHSD2/NWK products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1055.82
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP001323
Gene Name FCHSD2
Accession Number NM_014824
Gene ID 9873
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2223 bp
Gene Alias NWK,SH3MD3
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCAGCCGCCGCCGAGGAAGGTGAAAGTTACACAAGAACTGAAAAACATTCAAGTTGAGCAGATGACAAAACTTCAAGCCAAACATCAAGCAGAATGTGATTTGCTTGAAGATATGAGGACATTCAGTCAGAAGAAGGCTGCTATTGAAAGAGAGTATGCACAGGGTATGCAGAAGTTGGCTAGTCAATACCTGAAGAGAGATTGGCCTGGAGTAAAAGCTGATGATCGGAATGATTACAGGAGCATGTATCCCGTTTGGAAATCTTTTCTCGAGGGAACAATGCAGGTAGCCCAGTCTCGGATGAATATATGTGAAAACTATAAAAACTTCATTTCTGAGCCTGCAAGGACAGTGAGAAGCTTAAAAGAACAGCAACTAAAAAGGTGTGTGGACCAGTTGACAAAGATCCAAACTGAATTACAAGAGACAGTGAAAGATTTAGCTAAAGGCAAAAAGAAATACTTTGAGACTGAACAGATGGCTCATGCAGTACGAGAGAAAGCTGACATCGAGGCAAAATCTAAACTTAGTCTTTTTCAATCAAGAATCAGTTTACAGAAGGCAAGTGTAAAGTTAAAAGCCCGGCGATCTGAGTGTAATTCCAAAGCTACCCACGCAAGGAATGATTATCTTCTTACCCTAGCGGCAGCAAATGCACATCAGGATCGCTACTATCAAACAGATTTAGTTAACATTATGAAGGCTCTTGATGGAAATGTGTATGATCATCTCAAGGATTATTTAATAGCCTTCAGCCGGACTGAGCTAGAAACATGCCAAGCTGTGCAGAACACATTCCAGTTTTTATTAGAAAACTCCAGCAAGGTGGTCCGGGACTACAATCTTCAGCTGTTTTTGCAAGAAAACGCTGTATTTCACAAACCCCAGCCCTTCCAGTTCCAGCCTTGTGACAGTGATACTAGCCGACAGTTAGAATCAGAAACTGGGACCACAGAGGAGCACAGTCTAAATAAGGAAGCTCGAAAATGGGCCACACGTGTGGCACGTGAGCATAAAAACATTGTTCACCAACAACGGGTTCTAAATGATCTGGAGTGTCATGGAGCTGCTGTATCAGAACAAAGCCGAGCAGAGCTAGAACAGAAAATAGATGAAGCTAGAGAAAATATTCGTAAAGCAGAGATAATTAAATTGAAAGCTGAAGCCCGGTTGGACCTGCTAAAGCAGATTGGTGTTTCTGTGGACACATGGCTAAAGAGTGCCATGAACCAAGTAATGGAAGAACTGGAAAATGAGCGATGGGCCCGCCCTCCTGCAGTGACCAGTAATGGCACTTTACACTCGCTTAATGCAGATACCGAAAGAGAAGAAGGCGAAGAGTTTGAAGATAACATGGATGTTTTCGATGACAGCAGTTCCAGCCCTTCTGGCACCTTAAGAAATTATCCACTCACCTGCAAAGTTGTTTATTCCTACAAGGCTTCTCAACCAGATGAGTTGACCATTGAGGAACATGAGGTGTTAGAAGTGATTGAAGATGGAGATATGGAAGACTGGGTAAAGGCTCGAAATAAAGTTGGCCAAGTGGGTTATGTGCCAGAAAAGTACCTACAGTTTCCCACCTCGAACAGCCTCCTGAGCATGCTGCAGTCCCTGGCCGCTTTGGACAGTCGGTCACACACGTCCAGCAATTCCACGGAAGCAGAACTCGTTTCAGGCAGCCTCAACGGAGATGCCAGTGTATGTTTTGTGAAAGCACTTTATGATTATGAGGGCCAGACAGATGATGAGTTATCTTTTCCTGAGGGAGCAATAATCCGTATCTTGAACAAAGAAAACCAAGATGATGATGGCTTCTGGGAAGGGGAATTCAATGGGCGTATTGGAGTTTTCCCATCGGTGCTAGTGGAAGAACTTTCAGCCTCAGAAAATGGTGACACTCCATGGATGAGAGAGATTCAGATCTCTCCTTCCCCCAAGCCACACGCCTCCCTGCCTCCACTGCCGTTGTACGACCAGCCTCCCAGCAGCCCCTACCCCAGCCCAGATAAGAGGAGCTCCCTGTACTTTCCCCGGTCTCCTTCAGCAAACGAAAAAAGCCTTCATGCTGAGTCACCAGGATTCTCACAGGCATCAAGGCATACTCCTGAGACCTCATATGGCAAACTGCGACCTGTCCGGGCAGCTCCCCCTCCACCTACACAGAATCACCGAAGGCCAGCAGAGAAGATTGAAGATGTGGAAATCACACTGGTGTGA
ORF Protein Sequence MQPPPRKVKVTQELKNIQVEQMTKLQAKHQAECDLLEDMRTFSQKKAAIEREYAQGMQKLASQYLKRDWPGVKADDRNDYRSMYPVWKSFLEGTMQVAQSRMNICENYKNFISEPARTVRSLKEQQLKRCVDQLTKIQTELQETVKDLAKGKKKYFETEQMAHAVREKADIEAKSKLSLFQSRISLQKASVKLKARRSECNSKATHARNDYLLTLAAANAHQDRYYQTDLVNIMKALDGNVYDHLKDYLIAFSRTELETCQAVQNTFQFLLENSSKVVRDYNLQLFLQENAVFHKPQPFQFQPCDSDTSRQLESETGTTEEHSLNKEARKWATRVAREHKNIVHQQRVLNDLECHGAAVSEQSRAELEQKIDEARENIRKAEIIKLKAEARLDLLKQIGVSVDTWLKSAMNQVMEELENERWARPPAVTSNGTLHSLNADTEREEGEEFEDNMDVFDDSSSSPSGTLRNYPLTCKVVYSYKASQPDELTIEEHEVLEVIEDGDMEDWVKARNKVGQVGYVPEKYLQFPTSNSLLSMLQSLAALDSRSHTSSNSTEAELVSGSLNGDASVCFVKALYDYEGQTDDELSFPEGAIIRILNKENQDDDGFWEGEFNGRIGVFPSVLVEELSASENGDTPWMREIQISPSPKPHASLPPLPLYDQPPSSPYPSPDKRSSLYFPRSPSANEKSLHAESPGFSQASRHTPETSYGKLRPVRAAPPPPTQNHRRPAEKIEDVEITLV

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP2121-Ab Anti-FCSD2/ FCHSD2/ NWK monoclonal antibody
    Target Antigen GM-Tg-g-MP2121-Ag FCHSD2 VLP (virus-like particle)
    ORF Viral Vector pGMLP001323 Human FCHSD2 Lentivirus plasmid
    ORF Viral Vector vGMLP001323 Human FCHSD2 Lentivirus particle


    Target information

    Target ID GM-MP2121
    Target Name FCHSD2
    Gene ID 9873, 207278, 717996, 308864, 101094622, 485204, 539601, 100065828
    Gene Symbol and Synonyms FCHSD2,mKIAA0769,NWK,NWK1,SH3MD3
    Uniprot Accession O94868
    Uniprot Entry Name FCSD2_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000137478
    Target Classification Not Available

    Enables phosphatidylinositol-3,4,5-trisphosphate binding activity and phosphatidylinositol-3,4-bisphosphate binding activity. Involved in clathrin-dependent endocytosis and positive regulation of Arp2/3 complex-mediated actin nucleation. Located in plasma membrane. Colocalizes with clathrin-coated pit. [provided by Alliance of Genome Resources, Apr 2022]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.